info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Short-Read Sequencing Market Research Report Information By Product (Instruments, Consumables and Services), By Workflow (Pre-Sequencing, Sequencing and Data Analysis), By Application (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing (-DNA-based, -RNA-based) and Others), By End-Use (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/20278-HCR | 128 Pages | Author: Rahul Gotadki| December 2024

Short Read Sequencing Market Segmentation


Short-Read Sequencing Product Outlook (USD Billion, 2019-2032)




  • Instruments




  • Consumables




  • Services




Short-Read Sequencing Workflow Outlook (USD Billion, 2019-2032)




  • Pre-Sequencing




  • Sequencing




  • Data Analysis




Short-Read Sequencing Application Outlook (USD Billion, 2019-2032)




  • Whole Genome Sequencing




  • Whole Exome Sequencing




  • Targeted Sequencing & Resequencing




    • DNA-based




    • RNA-based






  • Others




Short-Read Sequencing End User Outlook (USD Billion, 2019-2032)




  • Academic & Research Institutes




  • Hospitals & Clinics




  • Pharmaceutical & Biotechnology Companies




  • Others




Short-Read Sequencing Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




    • North America Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • North America Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • North America Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • North America Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • US Outlook (USD Billion, 2019-2032)




    • US Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • US Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • US Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • US Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • CANADA Outlook (USD Billion, 2019-2032)




    • CANADA Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • CANADA Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • CANADA Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • CANADA Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others








  • Europe Outlook (USD Billion, 2019-2032)




    • Europe Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Europe Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Europe Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Europe Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Germany Outlook (USD Billion, 2019-2032)




    • Germany Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Germany Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Germany Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Germany Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • France Outlook (USD Billion, 2019-2032)




    • France Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • France Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • France Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • France Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • UK Outlook (USD Billion, 2019-2032)




    • UK Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • UK Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • UK Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • UK Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • ITALY Outlook (USD Billion, 2019-2032)




    • ITALY Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • ITALY Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • ITALY Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • ITALY Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • SPAIN Outlook (USD Billion, 2019-2032)




    • Spain Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Spain Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Spain Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Spain Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Rest Of Europe Outlook (USD Billion, 2019-2032)




    • Rest Of Europe Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • REST OF EUROPE Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • REST OF EUROPE Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • REST OF EUROPE Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others








  • Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Asia-Pacific Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Asia-Pacific Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Asia-Pacific Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Asia-Pacific Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • China Outlook (USD Billion, 2019-2032)




    • China Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • China Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • China Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • China Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Japan Outlook (USD Billion, 2019-2032)




    • Japan Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Japan Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Japan Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Japan Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • India Outlook (USD Billion, 2019-2032)




    • India Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • India Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • India Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • India Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Australia Outlook (USD Billion, 2019-2032)




    • Australia Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Australia Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Australia Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Australia Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




    • Rest of Asia-Pacific Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Rest of Asia-Pacific Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Rest of Asia-Pacific Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Rest of Asia-Pacific Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others








  • Rest of the World Outlook (USD Billion, 2019-2032)




    • Rest of the World Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Rest of the World Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Rest of the World Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Rest of the World Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Middle East Outlook (USD Billion, 2019-2032)




    • Middle East Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Middle East Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Middle East Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Middle East Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Africa Outlook (USD Billion, 2019-2032)




    • Africa Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Africa Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Africa Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Africa Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others






    • Latin America Outlook (USD Billion, 2019-2032)




    • Latin America Short-Read Sequencing by Product




      • Instruments




      • Consumables




      • Services






    • Latin America Short-Read Sequencing by Workflow




      • Pre-Sequencing




      • Sequencing




      • Data Analysis






    • Latin America Short-Read Sequencing by Application




      • Whole Genome Sequencing




      • Whole Exome Sequencing




      • Targeted Sequencing & Resequencing




        • DNA-based




        • RNA-based






      • Others






    • Latin America Short-Read Sequencing by End User




      • Academic & Research Institutes




      • Hospitals & Clinics




      • Pharmaceutical & Biotechnology Companies




      • Others







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL SHORT-READ SEQUENCING MARKET, BY PRODUCT

6.1. Overview

6.2. Instruments

6.3. Consumables

6.4. Services

7. GLOBAL SHORT-READ SEQUENCING MARKET, BY WORKFLOW

7.1. Overview

7.2. Pre-Sequencing

7.3. Sequencing

7.4. Data Analysis

8. GLOBAL SHORT-READ SEQUENCING MARKET, BY APPLICATION

8.1. Overview

8.2. Whole Genome Sequencing

8.3. Whole Exome Sequencing

8.4. Targeted Sequencing & Resequencing

8.4.1. DNA-based

8.4.2. RNA-based

8.5. Others

9. GLOBAL SHORT-READ SEQUENCING MARKET, BY END-USE

9.1. Overview

9.2. Academic & Research Institutes

9.3. Hospitals & Clinics

9.4. Pharmaceutical & Biotechnology Companies

9.5. Others

10. GLOBAL SHORT-READ SEQUENCING MARKET, BY REGION

10.1. Overview

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. France

10.2.3. UK

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. Asia-Pacific

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Australia

10.3.6. Rest of Asia-Pacific

10.4. Rest of the World

10.4.1. Middle East

10.4.2. Africa

10.4.3. Latin America

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global Short-Read Sequencing Market,

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Short-Read Sequencing Market,

11.7. Key developments and Growth Strategies

11.7.1. New Product Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2023

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Illumina, Inc.

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Products Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Thermo Fisher Scientific, Inc.

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Products Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Pacific Biosciences of California, Inc.

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Products Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. BGI

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Products Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Qiagen

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Products Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Agilent Technologies

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Products Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. PerkinElmer, Inc.

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Products Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. PROPHASE LABS, INC.

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Products Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Psomagen

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Products Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. AZENTA US INC.

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Products Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL SHORT-READ SEQUENCING MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL SHORT-READ SEQUENCING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GLOBAL SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 9 NORTH AMERICA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 10 NORTH AMERICA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 11 US: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 12 US: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 13 US: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 US: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 15 CANADA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 16 CANADA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 17 CANADA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 CANADA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 19 EUROPE: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 20 EUROPE: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 21 EUROPE: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 22 EUROPE: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 23 GERMANY: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 24 GERMANY: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 25 GERMANY: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 26 GERMANY: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 27 FRANCE: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 28 FRANCE: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 29 FRANCE: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 30 FRANCE: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 31 ITALY: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 32 ITALY: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 33 ITALY: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 34 ITALY: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 35 SPAIN: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 36 SPAIN: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 37 SPAIN: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 38 SPAIN: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 39 UK: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 40 UK: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 41 UK: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 42 UK: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 43 REST OF EUROPE: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 44 REST OF EUROPE: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 45 REST OF EUROPE: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 46 REST OF EUROPE: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 47 ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 48 ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 49 ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 50 ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 51 JAPAN: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 52 JAPAN: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 53 JAPAN: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 54 JAPAN: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 55 CHINA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 56 CHINA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 57 CHINA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 58 CHINA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 59 INDIA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 60 INDIA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 61 INDIA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 62 INDIA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 63 AUSTRALIA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 64 AUSTRALIA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 65 AUSTRALIA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 66 AUSTRALIA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 67 SOUTH KOREA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 68 SOUTH KOREA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 69 SOUTH KOREA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 70 SOUTH KOREA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 71 REST OF ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 72 REST OF ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 73 REST OF ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 74 REST OF ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 75 REST OF THE WORLD: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 76 REST OF THE WORLD: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 77 REST OF THE WORLD: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 78 REST OF THE WORLD: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 79 MIDDLE EAST: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 80 MIDDLE EAST: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 81 MIDDLE EAST: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 82 MIDDLE EAST: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 83 AFRICA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 84 AFRICA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 85 AFRICA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 86 AFRICA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

TABLE 87 LATIN AMERICA: SHORT-READ SEQUENCING MARKET, BY PRODUCT, 2019-2032 (USD BILLION)

TABLE 88 LATIN AMERICA: SHORT-READ SEQUENCING MARKET, BY WORKFLOW, 2019-2032 (USD BILLION)

TABLE 89 LATIN AMERICA: SHORT-READ SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 90 LATIN AMERICA: SHORT-READ SEQUENCING MARKET, BY END-USE, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SHORT-READ SEQUENCING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SHORT-READ SEQUENCING MARKET

FIGURE 4 GLOBAL SHORT-READ SEQUENCING MARKET, SHARE (%), BY PRODUCT, 2023

FIGURE 5 GLOBAL SHORT-READ SEQUENCING MARKET, SHARE (%), BY WORKFLOW, 2023

FIGURE 6 GLOBAL SHORT-READ SEQUENCING MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 7 GLOBAL SHORT-READ SEQUENCING MARKET, SHARE (%), BY END-USE, 2023

FIGURE 8 GLOBAL SHORT-READ SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 NORTH AMERICA: SHORT-READ SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 EUROPE: SHORT-READ SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 ASIA-PACIFIC: SHORT-READ SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 REST OF THE WORLD: SHORT-READ SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 13 GLOBAL SHORT-READ SEQUENCING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 14 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ILLUMINA, INC.: SWOT ANALYSIS

FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS

FIGURE 18 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SWOT ANALYSIS

FIGURE 20 BGI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 BGI: SWOT ANALYSIS

FIGURE 22 QIAGEN.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 QIAGEN.: SWOT ANALYSIS

FIGURE 24 AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 AGILENT TECHNOLOGIES: SWOT ANALYSIS

FIGURE 26 PERKINELMER, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 PERKINELMER, INC.: SWOT ANALYSIS

FIGURE 28 PROPHASE LABS, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 PROPHASE LABS, INC.: SWOT ANALYSIS

FIGURE 30 PSOMAGEN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 PSOMAGEN: SWOT ANALYSIS

FIGURE 32 AZENTA US INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 AZENTA US INC.: SWOT ANALYSIS

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.